The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction

FASEB Journal

Volumn 24, Issue 4, 2010, Pages 1073-1081

  Adler, Eric D ^a,f   Chen, Vincent C ^b   Bystrup, Anne ^a   Kaplan, Aaron D ^a   Giovannone, Steven ^c   Briley Saebo, Karen ^a   Young, Wilson ^a   Kattman, Steve ^d   Mani, Venkatesh ^a   Laflamme, Michael ^e   Zhu, Wei Zhong ^e   Fayad, Zahi ^a   Keller, Gordon ^d  

^a MOUNT SINAI HOSPITAL   (United States)

^b City of Hope   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cadiomyopathy; Cardiac regeneration; Embryonic stem cells

Indexed keywords

DOXYCYCLINE; NOTCH4 RECEPTOR; TETRACYCLINE; VASCULOTROPIN RECEPTOR 2; DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ANIMAL; BIOSYNTHESIS; CELL LINE; DISEASE MODEL; GENE EXPRESSION REGULATION; HEART STROKE VOLUME; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSPLANTATION;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STROKE VOLUME;

MURINAE; MUS;

EID: 77951647116     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-135426     Document Type: Article

References (31)

1. Taylor, D. A. (2001) Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr. Control. Trials Cardiovasc. Med. 2, 208-210
2. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., and Anversa, P. (2001) Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci. 938, 221-229; discussion 229-230
3. Yuasa, S., and Fukuda, K. (2008) Cardiac regenerative medicine. Circ. J. 72(Suppl. A), A49-A55
4. Rubart, M., and Field, L. J. (2006) Cell-based approaches for cardiac repair. Ann. N. Y. Acad. Sci. 1080, pp. 34-48
5. Herreros, J., Prosper, F., Perez, A., Gavira, J. J., Garcia-Velloso, M. J., Barba, J., Sanchez, P. L., Canizo, C., Rabago, G., Marti-Climent, J. M., Hernandez, M., Lopez-Holgado, N., Gonzalez-Santos, J. M., Martin-Luengo, C., and Alegria, E. (2003) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24, 2012-2020
6. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., Hornung, C. A., Zuba-Surma, E. K., Al-Mallah, M., and Dawn, B. (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Int. Med. 167, 989-997
7. Itescu, S., Kocher, A. A., and Schuster, M. D. (2002) Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function. Ann. Hematol. 2, S21-25
8. Penn, M. S., Francis, G. S., Ellis, S. G., Young, J. B., McCarthy, P. M., and Topol, E. J. (2002) Autologous cell transplantation for the treatment of damaged myocardium. Prog. Cardiovasc. Dis. 45, 21-32
9. Mummery, C. L., and van Laake, L. W. (2006) Progress and clashes in stem cell therapy research. Ned. Tijdschr. Geneeskd. 150, 943-947
10. Kattman, S. J., Huber, T. L., and Keller, G. M. (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723-732
11. Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., and Keller, G. M. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonicstem-cell-derived population. Nature 453, 524-528
12. Kattman, S. J., Huber, T. L., and Keller, G. M. (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell. 11, 723-732
13. Adler, E., Kattman, S., Chereshnev, I., G, A., Fayad, Z. A., Fehling, H. J., and Keller, G. (2006) Characterization and transplantation of embryonic stem cell derived cardiac precursor cells. In Keystone Symposium: Molecular Mechanisms of Cardiac Disease and Regeneration p. 101(A), Keystone Symposia, Silverthorne, CO, USA
14. Chen, V. C., Stull, R., Joo, D., Cheng, X., and Keller, G. (2008) Notch signaling respecifies the hemangioblast to a cardiac fate. Nat. Biotechnol. 26, 1169-1178
15. O'Connell, T. D., Rodrigo, M. C., and Simpson, P. C. (2007) Isolation and culture of adult mouse cardiac myocytes. Methods Mol. Biol. 357, 271-296
16. Ahlgren, U., Pfaff, S. L., Jessell, T. M., Edlund, T., and Edlund, H. (1997) Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385, 257-260
17. Moretti, A., Caron, L., Nakano, A., Lam, J., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., Sun, Y., Evans, S., Laugwitz, K. L., and Chien, K. R. (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151-1165
18. Houghton, F. D., Thonnissen, E., Kidder, G. M., Naus, C. C., Willecke, K., and Winterhager, E. (1999) Doubly mutant mice, deficient in connexin32 and -43, show normal prenatal development of organs where the two gap junction proteins are expressed in the same cells. Dev. Genet. 24, 5-12
19. Valiunas, V., Doronin, S., Valiuniene, L., Potapova, I., Zuckerman, J., Walcott, B., Robinson, R. B., Rosen, M. R., Brink, P. R., and Cohen, I. S. (2004) Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. 555, 617-626
20. Heubach, J. F., Graf, E. M., Leutheuser, J., Bock, M., Balana, B., Zahanich, I., Christ, T., Boxberger, S., Wettwer, E., and Ravens, U. (2004) Electrophysiological properties of human mesenchymal stem cells. J. Physiol. 554, 659-672 (Pubitemid 38219882)
21. Chaudhry, H. W., Dashoush, N. H., Tang, H., Zhang, L., Wang, X., Wu, E. X., and Wolgemuth, D. J. (2004) Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J. Biol. Chem. 279, 35858-35866
22. Levkau, B., Schafers, M., Wohlschlaeger, J., von Wnuck Lipinski, K., Keul, P., Hermann, S., Kawaguchi, N., Kirchhof, P., Fabritz, L., Stypmann, J., Stegger, L., Flogel, U., Schrader, J., Fischer, J. W., Hsieh, P., Ou, Y. L., Mehrhof, F., Tiemann, K., Ghanem, A., Matus, M., Neumann, J., Heusch, G., Schmid, K. W., Conway, E. M., and Baba, H. A. (2008) Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation 117, 1583-1593
23. Smith, R. R., Barile, L., Cho, H. C., Leppo, M. K., Hare, J. M., Messina, E., Giacomello, A., Abraham, M. R., and Marban, E. (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908
24. Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Rubart, M., Pasumarthi, K. B., Virag, J. I., Bartelmez, S. H., Poppa, V., Bradford, G., Dowell, J. D., Williams, D. A., and Field, L. J. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668
25. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., and Itescu, S. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436
26. Kolossov, E., Bostani, T., Roell, W., Breitbach, M., Pillekamp, F., Nygren, J. M., Sasse, P., Rubenchik, O., Fries, J. W., Wenzel, D., Geisen, C., Xia, Y., Lu, Z., Duan, Y., Kettenhofen, R., Jovinge, S., Bloch, W., Bohlen, H., Welz, A., Hescheler, J., Jacobsen, S. E., and Fleischmann, B. K. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J. Exp. Med. 203, 2315-2327
27. Vanlaake, L., Passier, R., Monshouwerkloots, J., Verkleij, A., Lips, D., Freund, C., Denouden, K., Wardvanoostwaard, D., Korving, J., and Tertoolen, L. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1, 9-24
28. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., O'Sullivan, C., Collins, L., Chen, Y., Minami, E., Gill, E. A., Ueno, S., Yuan, C., Gold, J., and Murry, C. E. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024
29. Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., and Dzau, V. J. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201
30. Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., Huber, I., Satin, J., Itskovitz-Eldor, J., and Gepstein, L. (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22, 1282-1289
31. Albert, J., Radomski, A., Soop, A., Sollevi, A., Frostell, C., and Radomski, M. W. (2003) Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol. Scand. 47, 407-410